牛皮关节炎:从诊断到治疗
Renuka Kannappan1, Sarah Kim1, Arthur Lau2
1Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.
Journal of clinical medicine
|November 27, 2025
概括
牛皮关节炎 (PsA) 是一种与牛皮相关的慢性炎症状况. 早期识别PsA对于预防关节损伤至关重要,需要皮肤科医生和风湿病学家之间的合作.
科学领域:
- 风湿病学和皮肤病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 牛皮关节炎 (PsA) 是一种与牛皮 (PsO) 相关的慢性,免疫媒介的炎症性疾病.
- 早期诊断PsA对于预防不可逆转的关节损伤至关重要.
- 这种病症会影响关节,体和轴骨架,带来诊断和治疗方面的挑战.
研究的目的:
- 提供关于牛皮关节炎 (PsA) 的全面概述.
- 突出PsA管理中的诊断和治疗挑战.
- 强调早期检测和跨学科治疗PsA患者的重要性.
主要方法:
- 对PsA流行病学,病原和临床特征的审查.
- 对诊断标准 (CASPAR,Moll & Wright) 和查工具的讨论.
- 探索当前和新兴的治疗策略,包括csDMARDs,bDMARDs和tsDMARDs.
主要成果:
- 这种病原性包括遗传倾向,环境触发因素和关键细胞因子 (TNF-α,IL-17,IL-23).
- 临床表现包括外围/轴关节炎,肠炎,手指炎和关节外特征.
- 有效的PsA管理需要涉及初级保健,皮肤病学和风湿病学的跨学科方法.
结论:
- 将初级保健,皮肤病学和风湿病学结合在一起的综合方法对于最佳的PsA患者结果至关重要.
- 及时干预和早期识别PsA可以显著改善患者的护理.
- 了解不断变化的治疗环境,包括向疗法,是管理PsA并发症的关键.
相关概念视频
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
01:21Rheumatic Heart Disease III: Medical Management
268
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
268
01:29Chronic Pancreatitis II: Collaborative Care
296
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
296
01:26Peripheral Artery Disease IV: Nursing Management
325
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
325
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
465
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
465
01:27Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229